Somatostatin receptor scintigraphy of malignant somatostatinoma with indium-111-pentetreotide

Journal of Nuclear Medicine

Volumn 38, Issue 6, 1997, Pages 886-887

  Schillaci, Orazio ^a,b   Annibale, Bruno ^a   Scopinaro, Francesco ^a   Delle Fave, Gianfranco ^a   Colella, Antonio Centi ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE   (Italy)

Author keywords

Indium 111 pentetreotide; Somatostatin receptor imaging; Somatostatinoma

Indexed keywords

PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR;

ADULT; ARTICLE; CASE REPORT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMAGE ANALYSIS; LIVER METASTASIS; PANCREAS SCINTISCANNING; PANCREAS TUMOR; PRIORITY JOURNAL; SOMATOSTATIN BLOOD LEVEL; SOMATOSTATINOMA; TUMOR DIAGNOSIS;

FEMALE; HUMANS; INDIUM RADIOISOTOPES; LIVER NEOPLASMS; MIDDLE AGED; OCTREOTIDE; PANCREATIC NEOPLASMS; PENTETIC ACID; RADIOPHARMACEUTICALS; RECEPTORS, SOMATOSTATIN; SOMATOSTATINOMA; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031006563     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Vinik AI, Strodel WE, Eckhauser FE, Moattari AR, Lloyd R. Somatostatinoma, PPomas, neurotensinomas. Semin Oncol 1987;14:263-281.
2. Harris GJ, Tio F, Cruz AB. Somatostatinoma: a case report and review of literature. J Surg Oncol 1987;36:8-16.
3. Tjon A, Tham RTO, Jansen JBMJ, Falke THM, Lamers CBHW. Imaging features of somatostatinoma: MR, CT, US and angiography. J Comput Assist Tomogr 1994; 18: 427-431.
4. Reubi JC, Krenning E, Lamberts SWJ, Kvols L. In vitro detection of somatostatin receptors in human tumors. Metabolism 1992;41:104-110.
5. 123I-Tyr3]octreotide: the Rotterdam experience with more than 1000 patients Eur J Nucl Med 1993;20:716-731.
6. Reubi JC, Waser B, Lamberts SWJ, Mengod G. Somatostatin (SIRH) messenger ribonucleic acid expression in human neuroendocrine and brain tumors using in situ hybridization histochemistry: comparison with SIRH receptor content. J Clin Endocrinol Metab 1993;76:642-647.
7. Reubi JC. Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging. J Nucl Med 1995;36:1825-1835.
8. Krenning EP, Kwekkeboom DJ, Oei HY, et al. Somatostatin receptor imaging of endocrine gastrointestinal tumors. Schweiz Med Wschr 1992;122:634-637.
9. Lamberts SWJ, Bakker WH, Reubi JC, Krenning EP. Somafostatin receptor imaging in the localization of endocrine tumors. N Engl J Med 1990;323:1246-1249.
10. Schillaci O, Scopinaro F, Angeletti S, et al. SPECT improves accuracy of somatostatin receptor scintigraphy in abdominal carcinoid tumors. J Nucl Med 1996;37:1452-1456.
11. Lamberts SWJ, Hofland LJ, van Koetsveld PM, et al. Parallel in vitro and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization and therapy. J Clin Endocrinol Metab 1990;71:566-574.
12. Jamar F, Fiasse R, Leners N, Pauwels S. Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management. J Nucl Med 1995;36:542-549.
13. Debas HT, Gittes G. Somatostatin analog therapy in functioning neuroendocrine gut tumors. Digestion 1993;54(suppl 1)68-71.
14. 123I-octreotide) in the detection and localization of carcinoid and islet cells tumors. Radiology 1993;49:1583-1591.
15. Kwekkeboom DJ, Krenning EP, Oei HY, van Eyck CHJ, Lamberts SWJ. Use of radiolabeled somatostatin to localize islet cell tumors. In: Mignon M, Jensen RT, eds. Endocrine tumors of the pancreas: frontiers of gastrointestinal research. Basel: Karger; 1995;23:298-308.